A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia

Clinical trial NCT07064486 · RECRUITING

Trial details

NCT number: NCT07064486
Sponsor: BrightGene Bio-Medical Technology Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes (T2DM)

Start date: 2025-07-04
Primary completion: 2026-07-31
Enrollment: 477

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.